文献速递前列腺癌

风险计算器实施对扩大盆腔淋巴结清扫候选选择的影响:三级转诊中心20年经验

Impact of Implementation of Risk Calculators for the Selection of Extended Pelvic Lymph Node Dissection Candidates: 20-year Experience from a Tertiary Referral Centre.
PubMed 文献 · Eur Urol Oncol · 2025-10-25

该研究基于2002至2023年7371例根治性前列腺切除术患者,评估术前淋巴结浸润风险工具(Briganti列线图)实施后的效果。结果显示pNx率变化范围为4.7%至38%(EAPC 8.9%,p<0.001),ePLND特异性并发症率下降(EAPC -4.6%,p=0.01),再入院率从8%降至2.3%(EAPC -13%,p=0.046),且pN0/1与pNx患者的生化复发和临床复发风险相似。结论认为列线图实施未损害淋巴结分期准确性,并减少了ePLND手术数量。

要点

  • Briganti列线图实施未损害淋巴结分期准确性。
  • ePLND特异性并发症率和再入院率显著下降。
  • pN0/1与pNx患者的生化复发和临床复发风险相似。

核心结论

  • 术前LNI风险列线图的实施未损害淋巴结分期准确性,减少了ePLND手术数量,并显著改善了RP患者的围手术期结局。

研究设计与样本

  • 回顾性研究纳入2002至2023年间在三级转诊中心接受RP±ePLND的7371例患者,该中心实施了术前Briganti列线图风险工具。
  • 使用估计年度百分比变化(EAPC)分析pN分期、ePLND特异性并发症和再入院率(2017年起可用,n=1161)的变化趋势。
  • 多变量线性回归分析手术年份与手术时间的关联(限于有经验外科医生机器人辅助病例,n=1484)。
  • 生存分析聚焦于Briganti 2012风险<5%患者(n=3774)中不同pN状态的生化复发(BCR)和临床复发(CR)风险。

主要发现

  • 总体pN0、pNx、pN1患者分别为5352例(73%)、1222例(17%)、797例(11%)。
  • 509例(6.9%)患者发生ePLND特异性并发症。
  • 研究期间pNx率范围为4.7%至38%(EAPC 8.9%,p<0.001),pN1率范围为14%至15%(EAPC 1.6%,95%CI 0.29-3,p=0.02)。
  • ePLND特异性并发症率下降(EAPC -4.6%,p=0.01),再入院率从8%降至2.3%(EAPC -13%,p=0.046)。
  • 手术年份独立关联手术时间缩短(β系数-6.3,p<0.001);pN0/1与pNx患者BCR风险(HR 1.1,p=0.4)和CR风险(HR 0.98,p=0.95)相似。

临床怎么用

  • 临床可采用Briganti列线图等术前风险工具筛选ePLND候选者,以减少不必要的手术并降低并发症。
  • 风险工具的实施需结合定期评估淋巴结分期准确性,确保肿瘤学安全性。

局限性

  • 研究缺乏用于决定ePLND的个体LNI风险数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Several models predicting the lymph node invasion (LNI) risk in radical prostatectomy (RP) patients have been proposed to identify extended pelvic lymph node dissection (ePLND) candidates. We hypothesised that the implementation of these tools in the clinical practice would not hamper nodal staging accuracy, with benefits in perioperative outcomes. METHODS: A total of 7371 patients treated with RP ± ePLND between 2002 and 2023 were identified at a referral centre where the use of preoperative risk tools (Briganti nomograms) was implemented. Differences in pN stage (pNx vs pN0 vs pN1), ePLND-specific complications, and readmission rates (available from 2017, n = 1161) were displayed using the estimated annual percent change (EAPC). Multivariable linear regression tested the association of year of surgery with operative time, among cases performed with a robot-assisted approach by experienced surgeons (n = 1484). Survival analyses focused on biochemical (BCR) and clinical (CR) recurrence risks according to pN status (pNx vs pN0/1) in patients with a Briganti 2012 risk of <5% (n = 3774). KEY FINDINGS AND LIMITATIONS: Overall, 5352 (73%) versus1222 (17%) versus 797 (11%) patients were at pN0 versus pNx versus pN1 stage. A total of 509 (6.9%) patients experienced ePLND-specific complications. The rates of pNx and pN1 during the study period ranged from 4.7% to 38% (EAPC: 8.9%, p < 0.001) and from 14% to 15% (EAPC: 1.6%, 95% confidence interval 0.29-3, p = 0.02), respectively. Decreased ePLND-specific complication rates were observed over the study period (EAPC: -4.6%, p = 0.01). Readmission rates decreased from 8% to 2.3% (EAPC: -13%, p = 0.046). Year of surgery was independently associated with reduced operative time (β coefficient -6.3, p < 0.001). In multivariable Cox-regression models, pN0/1 patients exhibited similar BCR (hazard ratio [HR]: 1.1, p = 0.4) and CR (HR: 0.98, p = 0.95) risks to pNx patients. A study limitation is represented by the lack of individual LNI risk data on which the decision to perform ePLND was based. CONCLUSIONS AND CLINICAL IMPLICATIONS: The implementation of nomograms for preoperative LNI risk did not hamper nodal staging accuracy and reduced the number of ePLND procedures performed, with significant benefits in terms of RP patients' outcomes.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Barletta F, Scuderi S, Scilipoti P, et al. Impact of Implementation of Risk Calculators for the Selection of Extended Pelvic Lymph Node Dissection Candidates: 20-year Experience from a Tertiary Referral Centre. Eur Urol Oncol. 2025. PMID: 41429699. doi:10.1016/j.euo.2025.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。